Seaport Therapeutics, Inc. cotiza a 16.08 USD y tiene una capitalización bursátil de $861M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in …
| Periodo | 2026-11 | 2026-08 | 2026-06 |
|---|---|---|---|
| Real | — | $-1.78 | $-10.34 |
| Estimado | $-0.57 | $-0.66 | $-3.88 |
| Sorpresa | — | -169.7% | -166.5% |
| Métrica | SPTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 17.46 | 2.84 | +14.62 |
| Debt / Equity | — | 0.28 | — |